Eli Lilly (LLY) Shares Repurchased (2016 - 2025)
Historic Shares Repurchased for Eli Lilly (LLY) over the last 14 years, with Q3 2025 value amounting to $708.1 million.
- Eli Lilly's Shares Repurchased rose 5873.12% to $708.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 billion, marking a year-over-year increase of 94330.87%. This contributed to the annual value of $2.5 billion for FY2024, which is 23333.33% up from last year.
- As of Q3 2025, Eli Lilly's Shares Repurchased stood at $708.1 million, which was up 5873.12% from $692.2 million recorded in Q2 2025.
- In the past 5 years, Eli Lilly's Shares Repurchased ranged from a high of $2.1 billion in Q4 2024 and a low of $446.1 million during Q3 2024
- Over the past 5 years, Eli Lilly's median Shares Repurchased value was $750.0 million (recorded in 2021), while the average stood at $955.6 million.
- In the last 5 years, Eli Lilly's Shares Repurchased crashed by 5000.0% in 2023 and then soared by 5873.12% in 2025.
- Eli Lilly's Shares Repurchased (Quarter) stood at $750.0 million in 2021, then skyrocketed by 100.0% to $1.5 billion in 2022, then plummeted by 50.0% to $750.0 million in 2023, then surged by 173.85% to $2.1 billion in 2024, then tumbled by 65.52% to $708.1 million in 2025.
- Its Shares Repurchased stands at $708.1 million for Q3 2025, versus $692.2 million for Q2 2025 and $1.2 billion for Q1 2025.